Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Methods Mol Biol ; 2377: 89-107, 2022.
Article in English | MEDLINE | ID: mdl-34709612

ABSTRACT

Genome-wide CRISPR and siRNA screening methodologies are powerful tools that are aptly suited to the discovery of essential genes. In this chapter, we outline our methods to conduct sequential CRISPR and siRNA screens to quickly and efficiently identify essential genes within a collection of cell lines. The utilization of both screening methodologies provides a pipeline that minimizes costs and time while enabling the robust detection of candidate genes.


Subject(s)
Clustered Regularly Interspaced Short Palindromic Repeats , Genes, Essential , CRISPR-Cas Systems/genetics , Cell Line , RNA, Small Interfering/genetics
2.
Chem Res Toxicol ; 30(11): 2023-2032, 2017 11 20.
Article in English | MEDLINE | ID: mdl-28972744

ABSTRACT

DNA damage impinges on genetic information flow and has significant implications in human disease and aging. Lucidin-3-O-primeveroside (LuP) is an anthraquinone derivative present in madder root, which has been used as a coloring agent and food additive. LuP can be metabolically converted to genotoxic compound lucidin, which subsequently forms lucidin-specific N2-2'-deoxyguanosine (N2-dG) and N6-2'-deoxyadenosine (N6-dA) DNA adducts. Lucidin is mutagenic and carcinogenic in rodents but has low carcinogenic risks in humans. To understand the molecular mechanism of low carcinogenicity of lucidin in humans, we performed DNA replication assays using site-specifically modified oligodeoxynucleotides containing a structural analogue (LdG) of lucidin-N2-dG DNA adduct and determined the crystal structures of DNA polymerase (pol) κ in complex with LdG-bearing DNA and an incoming nucleotide. We examined four human pols (pol η, pol ι, pol κ, and Rev1) in their efficiency and accuracy during DNA replication with LdG; these pols are key players in translesion DNA synthesis. Our results demonstrate that pol κ efficiently and accurately replicates past the LdG adduct, whereas DNA replication by pol η, pol ι is compromised to different extents. Rev1 retains its ability to incorporate dCTP opposite the lesion albeit with decreased efficiency. Two ternary crystal structures of pol κ illustrate that the LdG adduct is accommodated by pol κ at the enzyme active site during insertion and postlesion-extension steps. The unique open active site of pol κ allows the adducted DNA to adopt a standard B-form for accurate DNA replication. Collectively, these biochemical and structural data provide mechanistic insights into the low carcinogenic risk of lucidin in humans.


Subject(s)
Anthraquinones/metabolism , Carcinogens/metabolism , DNA Adducts/metabolism , DNA Damage , DNA Replication , DNA-Directed DNA Polymerase/metabolism , Anthraquinones/chemistry , Carcinogens/chemistry , Crystallography, X-Ray , DNA Adducts/chemistry , DNA Adducts/genetics , DNA-Directed DNA Polymerase/chemistry , Humans , Models, Molecular
SELECTION OF CITATIONS
SEARCH DETAIL